Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers

Background:We previously conducted gene expression microarray analyses to identify novel indicators for colorectal cancer (CRC) metastasis and prognosis from which we identified PVT-1 as a candidate gene. PVT-1, which encodes a long noncoding RNA, mapped to chromosome 8q24 whose copy-number amplification is one of the most frequent events in a wide variety of malignant diseases. However, PVT-1 molecular mechanism of action remains unclear.Methods:We conducted cell proliferation and invasion assays using colorectal cancer cell lines transfected with PVT-1siRNA or negative control siRNA. Gene expression microarray analyses on these cell lines were also carried out to investigate the molecular function of PVT-1. Further, we investigated the impact of PVT-1 expression on the prognosis of 164 colorectal cancer patients by qRT–PCR.Results:CRC cells transfected with PVT-1 siRNA exhibited significant loss of their proliferation and invasion capabilities. In these cells, the TGF-β signalling pathway and apoptotic signals were significantly activated. In addition, univariate and multivariate analysis revealed that PVT-1 expression level was an independent risk factor for overall survival of colorectal cancer patients.Conclusion:PVT-1, which maps to 8q24, generates antiapoptotic activity in CRC, and abnormal expression of PVT-1 was a prognostic indicator for CRC patients.

[1]  E. Lander,et al.  Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.

[2]  W. Gerald,et al.  The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer. , 2008, Cancer research.

[3]  N. Caplen,et al.  p53-dependent Induction of PVT1 and miR-1204* , 2011, The Journal of Biological Chemistry.

[4]  S. Salzberg,et al.  The Transcriptional Landscape of the Mammalian Genome , 2005, Science.

[5]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[6]  Stuart H. Orkin,et al.  The SWI/SNF complex — chromatin and cancer , 2004, Nature Reviews Cancer.

[7]  S. Kern,et al.  G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Mattick,et al.  Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.

[9]  Paulo P. Amaral,et al.  The Eukaryotic Genome as an RNA Machine , 2008, Science.

[10]  K. Mimori,et al.  Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis. , 2013, Oncology reports.

[11]  K. Mimori,et al.  Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin‐conjugating enzyme E2C gene expression , 2007, International journal of cancer.

[12]  Peter J. Park,et al.  Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters , 2013, Proceedings of the National Academy of Sciences.

[13]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[14]  Celso A. Espinoza,et al.  B2 RNA binds directly to RNA polymerase II to repress transcript synthesis , 2004, Nature Structural &Molecular Biology.

[15]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[16]  S. Sunkin,et al.  Specific expression of long noncoding RNAs in the mouse brain , 2008, Proceedings of the National Academy of Sciences.

[17]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Paulo P. Amaral,et al.  Noncoding RNA in development , 2008, Mammalian Genome.

[19]  F. Grosveld,et al.  Xist RNA Is Confined to the Nuclear Territory of the Silenced X Chromosome throughout the Cell Cycle , 2008, Molecular and Cellular Biology.

[20]  Jeffrey R Marks,et al.  Gene Expression Patterns That Characterize Advanced Stage Serous Ovarian Cancers , 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

[21]  Howard Y. Chang,et al.  Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.

[22]  D. Huang,et al.  Interleukin-27 induces interferon-inducible genes: analysis of gene expression profiles using Affymetrix microarray and DAVID. , 2012, Methods in molecular biology.

[23]  L. You,et al.  Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. , 2011, Biochemical and biophysical research communications.

[24]  J. Bishop,et al.  The PVT gene frequently amplifies with MYC in tumor cells , 1989, Molecular and cellular biology.

[25]  Wen-Lin Kuo,et al.  Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer , 2007, Clinical Cancer Research.

[26]  Michael F. Lin,et al.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals , 2009, Nature.

[27]  S. Miyano,et al.  Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. , 2011, Cancer research.

[28]  D. Zimonjic,et al.  Chromosome‐mediated alterations of the MYC gene in human cancer , 2002, Journal of cellular and molecular medicine.

[29]  Jia-Yun Chen,et al.  TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. , 2002, Nature cell biology.

[30]  K. Miyazono,et al.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins. , 1997, Nature.

[31]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[32]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[33]  Yi Sun,et al.  Smad4 Inhibits Tumor Growth by Inducing Apoptosis in Estrogen Receptor-α-positive Breast Cancer Cells* , 2005, Journal of Biological Chemistry.

[34]  Jia-Yun Chen,et al.  TGF-β induces apoptosis through Smad-mediated expression of DAP-kinase , 2002, Nature Cell Biology.

[35]  M. L. Alvarez,et al.  Functional Characterization of the Plasmacytoma Variant Translocation 1 Gene (PVT1) in Diabetic Nephropathy , 2011, PloS one.

[36]  C. Heldin,et al.  Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration. , 1999, Cancer research.

[37]  Celso A. Espinoza,et al.  Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. , 2008, Molecular cell.

[38]  Howard Y. Chang,et al.  Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.